de la Haba-Rodriguez J - Search Results

1

Research advances in apoptosis-mediated cancer therapy: a review.

Lopez-Beltran A, Maclennan GT, de la Haba-Rodriguez J, Montironi R, Cheng L. Lopez-Beltran A, et al. Anal Quant Cytol Histol. 2007 Apr;29(2):71-8. Anal Quant Cytol Histol. 2007. PMID: 17484270 Review.

2

Nitric oxide and cancer: the emerging role of S-nitrosylation.

Aranda E, López-Pedrera C, De La Haba-Rodriguez JR, Rodriguez-Ariza A. Aranda E, et al. Curr Mol Med. 2012 Jan;12(1):50-67. doi: 10.2174/156652412798376099. Curr Mol Med. 2012. PMID: 22082481 Review.

3

Altered S-nitrosothiol homeostasis provides a survival advantage to breast cancer cells in HER2 tumors and reduces their sensitivity to trastuzumab.

Cañas A, López-Sánchez LM, Peñarando J, Valverde A, Conde F, Hernández V, Fuentes E, López-Pedrera C, de la Haba-Rodríguez JR, Aranda E, Rodríguez-Ariza A. Cañas A, et al. Biochim Biophys Acta. 2016 Apr;1862(4):601-610. doi: 10.1016/j.bbadis.2016.02.005. Epub 2016 Feb 6. Biochim Biophys Acta. 2016. PMID: 26854735 Free article.

4

Adjuvant treatment in elderly patients with breast cancer: critical review of clinical practice.

de la Haba Rodríguez JR, Méndez Vidal MJ, Gómez España A, Serrano Blanch R, Tejera Vaquerizo A, Barneto Aranda I, Aranda Aguilar E. de la Haba Rodríguez JR, et al. Am J Clin Oncol. 2003 Aug;26(4):398-401. doi: 10.1097/01.COC.0000026484.30773.89. Am J Clin Oncol. 2003. PMID: 12902894

5

Simultaneous inhibition of EGFR/VEGFR and cyclooxygenase-2 targets stemness-related pathways in colorectal cancer cells.

Valverde A, Peñarando J, Cañas A, López-Sánchez LM, Conde F, Hernández V, Peralbo E, López-Pedrera C, de la Haba-Rodríguez J, Aranda E, Rodríguez-Ariza A. Valverde A, et al. PLoS One. 2015 Jun 24;10(6):e0131363. doi: 10.1371/journal.pone.0131363. eCollection 2015. PLoS One. 2015. PMID: 26107817 Free PMC article.

6

Nitric oxide-targeted therapy inhibits stemness and increases the efficacy of tamoxifen in estrogen receptor-positive breast cancer cells.

López-Sánchez LM, Mena R, Guil-Luna S, Mantrana A, Peñarando J, Toledano-Fonseca M, Conde F, De la Haba-Rodríguez JR, Aranda E, Rodríguez-Ariza A. López-Sánchez LM, et al. Lab Invest. 2021 Mar;101(3):292-303. doi: 10.1038/s41374-020-00507-z. Epub 2020 Dec 1. Lab Invest. 2021. PMID: 33262438 Free article.

7

SEOM-GETTHI clinical guideline for the practical management of molecular platforms (2021).

de la Haba-Rodriguez J, Lloret FF, Salgado MAV, Arce MO, Gutiérrez AC, Jiménez JG, Zambrano CB, Alonso RMR, López RL, Salas NR. de la Haba-Rodriguez J, et al. Clin Transl Oncol. 2022 Apr;24(4):693-702. doi: 10.1007/s12094-022-02817-8. Epub 2022 Apr 1. Clin Transl Oncol. 2022. PMID: 35362851 Free PMC article.

8

Impact of breast cancer treatment on fertility.

de la Haba-Rodríguez J, Calderay M. de la Haba-Rodríguez J, et al. Breast Cancer Res Treat. 2010 Sep;123 Suppl 1:59-63. doi: 10.1007/s10549-010-1069-7. Epub 2010 Aug 14. Breast Cancer Res Treat. 2010. PMID: 20711656 No abstract available.

9

Soluble dipeptidyl peptidase IV (CD-26) in serum of patients with colorectal carcinoma.

de la Haba-Rodríguez J, Macho A, Calzado MA, Blázquez MV, Gómez MA, Muñoz EE, Aranda E. de la Haba-Rodríguez J, et al. Neoplasma. 2002;49(5):307-11. Neoplasma. 2002. PMID: 12458328

10

Clinical trials: bad combinations or bad designs.

de la Haba-Rodríguez J, Gómez A, Aranda E. de la Haba-Rodríguez J, et al. Clin Transl Oncol. 2005 Nov;7(10):419-20. doi: 10.1007/BF02716591. Clin Transl Oncol. 2005. PMID: 16373049 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

69 results

Search Page